The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas

Mitogen-activated protein kinases (MAPKs) include ERK, p38, and JNK MAPK subfamilies, which are crucial regulators of cellular physiology, cell pathology, and many diseases including cancers. For the MAPK signaling system in pituitary adenomas (PAs), the activation of ERK signaling is generally thou...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Miaolong, Wang, Ya, Zhan, Xianquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558377/
https://www.ncbi.nlm.nih.gov/pubmed/31231308
http://dx.doi.org/10.3389/fendo.2019.00330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558377/
https://www.ncbi.nlm.nih.gov/pubmed/31231308
http://dx.doi.org/10.3389/fendo.2019.00330

Ejemplares similares